INTRODUCTION
Mucormycosis, an infection caused by fungi of the class zygomycetes, order mucorales, is usually found in immunocompromised patients, with disease manifestations differing for each of the underlying condition. The rhinocerebral form can be found most often in diabetic patients, [1] the pulmonary and disseminated manifestations are in association with hematological malignancies [2, 3] and the gastrointestinal form of the disease is primarily found in patients suffering from extreme malnutrition. Mucormycosis has also been recognized in patients requiring hemodialysis, [4] and in immunosuppressed patients following organ transplantation. [5] Gastric mucormycosis is a rare disease with a reported fatal outcome of 98%. [6] Manifestations range from colonization of peptic ulcer to infiltrative disease with vascular invasion and dissemination. [7] Access this article online His ultrasound whole abdomen was done which showed fatty liver no evidence of ascites was there. Upper GI endoscopy was performed which showed large ulcer involving antrum and distal body of stomach.
Histological examination of gastric biopsy showed areas of ulceration and necrosis with inflammatory granulation, within areas of necrosis are seen many broad aseptate fungal hyphae of mucor ( Figure 1 ). Helicobacter pylori and other microorganisms were absent.
International Journal of Medical Science and Public Health 820 2017 | Vol 6 | Issue 4 maximum of 4.4 mg/dl after 15 days of antifungal therapy nevertheless, daily administration of the full dose was continued for an additional 3 weeks until a total dose of 1,850 mg of amphotericin B was given.
After the withdrawal of amphotericin B therapy, the serum creatinine level decreased rapidly to a stable value of 1.8 mg/dl. Repeated gastroscopic follow-up examinations confirmed complete healing of the ulcer.
DISCUSSION
Zygomycetes are ubiquitous fungi, often present in soil and decaying organic material. Despite their widespread distribution, disease manifestations are generally restricted to severely immunocompromised patients, attesting to the low intrinsic virulence potential of these organisms. [8] The most common infections caused by Zygomycetes include those caused by members of the four genera Rhizopus, Rhizomucor, Absidia, and Mucor, with Rhizopus oryzae being the species most frequently isolated from patients, [9] whereas Rhizopus stolonifer has never been implicated in a human infection. Gastrointestinal infection is thought to arise from the ingestion of spores and has been traditionally linked to extreme malnutrition. [2, 7] In nontransplant recipients the stomach was the most frequently involved site, with 67% of all manifestations being gastrointestinal and with a reported mortality rate of 98%. [8] Histologically, invasion of vessel walls producing thrombosis, hemorrhage, necrosis, and ulceration of the tissue with an almost uniformly fatal outcome has been separated from colonization of ulcer disease, with a more favorable prognosis. [6] More recently, an additional category of invasive disease with infiltration of viable tissue but without vascular involvement has been proposed, but it still represents severe disease. [10] After a review of the literature, we found that species identification of the fungi by culture has been completed only for a minority of patients. Isolation of R. oryzae has been reported only once, from a perforated stomach wall of an infant (32 weeks of gestation) with respiratory distress syndrome, sepsis, and a nasogastric tube. [11] Several risk factors might have favored this rare infection in our patient. Uremia implies alterations in the immune system, with granulocyte dysfunction and depressed cell-mediated immunity. [12] Normal human serum inhibits the growth of Rhizopus spp., [3] while the sera of uremic patients decrease the inhibitory effects of macrophages on spore germination. [5] Furthermore, metabolic acidosis, another feature of uremia, increases the availability of iron, which is a known growth factor for Rhizopus spp. Antirejection therapy with high doses of corticosteroids could have exerted an additional important risk factor.
Therapy of mucormycosis with amphotericin B remains standard. Currently applied azole derivatives do not appear to be effective, [13] despite a single report of a cure of invasive gastrointestinal mucormycosis in a patient with AIDS achieved with ketoconazole. [1] Surgical intervention was also considered for our patient. However, the stable clinical condition, an early causative diagnosis and treatment, as well as frequent gastroscopic follow-up examinations justified an attempt for conservative management.
CONCLUSION
This is a rare case of invasive gastric mucormycosis localized exclusively in the stomach. The stable clinical condition, an early causative diagnosis and treatment, as well as frequent gastroscopic follow-up examinations justified an attempt for conservative management. 
